AbCellera Biologics Inc. SEC filings ABCL
AbCellera Biologics Inc. has 322 filings in SEC EDGAR's recent list, going back to Apr 6, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 13, 2026 | — |
| 424B5 | Prospectus supplement | Aug 11, 2026 | — |
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 27, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| S-8 | Employee stock plan registration | Feb 20, 2024 | — |
| S-8 | Employee stock plan registration | Feb 21, 2023 | — |
| POS AM | Filing | Jul 22, 2022 | — |
| S-3ASR | Automatic shelf registration | Feb 25, 2022 | — |
| POS AM | Filing | Feb 25, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2022 | — |
| 424B3 | Prospectus | Feb 16, 2022 | — |
| 424B3 | Prospectus | Dec 7, 2021 | — |
| 424B3 | Prospectus | Dec 7, 2021 | — |
| 424B3 | Prospectus | Nov 12, 2021 | — |
| 424B3 | Prospectus | Nov 4, 2021 | — |
| 424B3 | Prospectus | Sep 23, 2021 | — |
| 424B3 | Prospectus | Sep 15, 2021 | — |
| 424B3 | Prospectus | Aug 17, 2021 | — |
| 424B3 | Prospectus | Jul 15, 2021 | — |
| 424B3 | Prospectus | Jun 25, 2021 | — |
| 424B3 | Prospectus | Jun 22, 2021 | — |
| S-1 | Registration statement | Jun 10, 2021 | — |
| S-8 | Employee stock plan registration | Dec 15, 2020 | — |
| 424B4 | Prospectus | Dec 14, 2020 | — |
| S-1MEF | Filing | Dec 10, 2020 | — |
| S-1/A | Amended registration statement | Dec 10, 2020 | — |
| S-1/A | Amended registration statement | Dec 7, 2020 | — |
| S-1/A | Amended registration statement | Nov 25, 2020 | — |
| S-1 | Registration statement | Nov 20, 2020 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABCL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1703057
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.